| Summary: | Juraj Payer, Kristina Brazdilova, Peter Jackuliak5th Department of Internal Medicine, Medical Faculty of Comenius University and Faculty Hospital Bratislava, Bratislava, SlovakiaAbstract: An excess amount of glucocorticoids represents the primary and most frequent etiological factor influencing secondary osteoporosis. Patients receiving glucocorticoids, but also those with the endogenous form of hypercorticism, are at high risk for the loss of bone density, with the subsequent occurrence of pathological fractures. In this review, we summarize the currently available methods of prevention and the treatment of glucocorticoid-induced osteoporosis. We also include a proposal for both a prophylactic and therapeutic approach that takes into account the risk factors typical for long-term users of glucocorticoids.Keywords: glucocorticoid-induced osteoporosis, bone mineral density, osteoporotic fractures, calcium and vitamin D, bisphosphonates, teriparatide
|
|---|
